This morning, we added small capsupercomputer stock Cray Inc (NASDAQ: CRAY) back into our Elite Opportunity Pro (EOP) newsletter portfolio. The stock would be a familiar name to subscribers as we had it in our portfolio back in 2012 asa potentially goodlow risk longer-term play. Shares were trading at the $12 level at the time and eventually hit $40+ per share before coming back down to earth repeatedly:....More>>>
Markets have been holding near their highs as we begin the New Year, and this has largely been propped up by the Dow Jones Industrial Average (DJIA) and larger companies making gains to close out the year. But what about the little guy? There were a few companies that made massive runs on Tuesday that you might not have heard of. Now some of these moves were earth-shattering for the company and....More>>>
It’s mind bending. Scientists believe it is now possible to wind back the biological clock. Aging would not only stop. It would reverse.
Last month, researchers at the Salk Institute in La Jolla, California published a ground breaking study in the medical journal, Cell. Using genetic modification, Juan Carlos Izpisua Belmonte, Alejandro Ocampo and other Salk scientists....More>>>
With six catalysts driving the gold price forecast, the yellow metal should easily eclipse its all-time high of $1,895 within the next few years.
That’s a 53% gain from the current gold price of $1,236 an ounce.
While one or two strong catalysts can be enough to drive an investment higher, multiple catalysts increase the likelihood of truly monster gains.
President Trump’s decision to withdrawal from the Paris Accord is not just a terrible decision for the planet and our children. It could quickly lead to a worldwide boycott of Americans goods and services as well as travel to the U.S.
Such a boycott doesn’t need to be enacted by foreign governments via formal sanctions. It can be arranged by prominent global citizens who realize....More>>>
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the biggest names in the biotechnology sector. The company has already-approved assets (of which there are six so far) and pipeline-based development drugs (of which there are around 15 right now) designed to target a whole host of different indications, from eye disease to heart disease, to pain, cancer, infectious diseases and rare diseases.
Editor’s Note: Chris Johnson has worked in finance for more than 20 years, holding the titles Director of Research and Director of Quantitative Analysis (“quants” are kind of like the rocket scientists of investing) at a well-known equity and options research firm. You’re going to be hearing a lot more from him soon, but he wanted us to get in touch right away with this....More>>>
Theres no clear consensus on how Apple Inc. (NSDQ:AAPL)will perform in China, as retail channel checks suggestdemand is robust in China.
However,the Chinese retail commentary wasnt very supportive in the month of October, and Im guessing that was attributed to Apples cautious stance on channel inventory, as Apple reduced channel inventory by a couple of weeks, which reduced production at....More>>>
Peter Thiel at Hy! Summit in 2014
Donald Trump named Silicon Valley billionaire Peter Thiel to the executive committee of his presidential transition team on Friday.
Thiel has shown strong support for the president-elect throughout the election…
He notably donated $1.25 million to the campaign at the Republican National Convention in July. He also spoke at the event,....More>>>